Abstract
The U.S. Market for OTC anti-infective products surpassed the $2 billion mark
last year. Although overall growth is sluggish, the market is a proven revenue
source for a number of major brands, and there have been some nice surprises
in the performance of some categories, such as first-aid related antiseptic
and antibiotic products.
This comprehensive report examines all aspects of the U.S. OTC market,
including 5-year sales performance by brand and by marketer for the following
categories of products:
- Antifungals
- Jock-Itch Products
- Vaginal Yeast Infection Products
- Athlete's Foot Products
- Antiseptic/Antibiotics
- Antiparasitics
The report also provides in-depth coverage consumer demographic and
preferences and analyses of sales channels. Th competitive picture is
extensively examined in terms of market share by player, market share by
brand, promotional spend, new product development, and much more. Profiles of
the top competitors round out the picture of the marketplace.
The methodology for assembling this report included a combination of primary
and secondary research. Information Resources Inc. (IRI) and Simmons Market
Research Bureau (SMRB) provided primary research findings; secondary research
included such material as published reports, news stories, and company
literature and documents.